Symposium: Public Health And Human Rights: The Work Ahead Of Us
On December 5, the Johns Hopkins Bloomberg School of Public Health and The New York Academy of Sciences will host a half-day symposium to mark the 60th Anniversary of the Universal Declaration of Human Rights. The event, "Public Health and Human Rights: The Work Ahead of Us," will evaluate progress in public health and human rights over the last 60 years. Navanethem Pillay, SJD, LLM, the United Nations High Commissioner for Human Rights will be the keynote speaker.

Trellis(R) Peripheral Infusion System Removes Blood Clots In Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
Clinical data from a prospective registry presented this week at the 35th Annual Veith Symposium shows DVT treatment with the Trellis(R) Peripheral Infusion System from Bacchus Vascular, Inc. (Santa Clara, CA) successfully breaks up the blood clot in most patients in about 20 minutes. This technique, called isolated pharmacomechanical thrombolysis, restores blood flow more quickly and safely than current catheter-directed thrombolysis (CDT) techniques.

Adult Stem Cells - Biology And Clinical Applications Conference, Griffith University, Australia
The National Centre for Adult Stem Cell Research looks forward to welcoming delegates to the first Adult Stem Cell - Biology and Clinical Applications Conference from the 26-28 November 2008 at the Ian Hanger Recital Hall, Queensland Conservatorium of Music, Griffith University.

BioTime CEO Dr. Michael West Discusses State Of Stem Cell Industry Under Obama Administration At Wisconsin Academy Of Sciences, Arts, And Letters
BioTime, Inc. (OTCBB:BTIM) Chief Executive Officer Michael West, Ph.D. delivered the keynote presentation on Wednesday, November 19, at a meeting in Madison, Wisconsin commemorating the 10th anniversary of the publication describing the first derivation and culturing of human embryonic stem cells. Dr. West's presentation is titled "Opportunities and Challenges of Commercializing Stem Cell Research.

E-Detailing And ROI: Planning, Metrics, And Best Practices
The state of the pharmaceutical union has meant massive marketing effort put toward detailing, but a dramatically less receptive audience. This is changing as sales forces around the world are being slashed. e-Detailing represents a way to maximize sales force efforts, cut costs and increase both interaction with physicians and bottom line sales and profit.

Researchers Define Ideal Time For Stem Cell Collection For Parkinson's Disease Therapy
Researchers have identified a stage during dopamine neuron differentiation that may be an ideal time to collect human embryonic stem cells for transplantation to treat Parkinson's disease, according to data presented at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience. Lorraine Iacovitti, Ph.D.

Cedars Sinai Researchers Present New Findings At Neuroscience Meetings
Researchers from Cedars-Sinai Medical Center are presenting findings during the 38th annual meeting of the Society for Neuroscience. Neuroscience 2008 is at the Walter E. Washington Convention Center in Washington, D.C., Nov. 15 through 19, and is expected to draw more than 30,000 attendees from around the world.

AACR Cancer Prevention Meeting: Georgetown University Medical Center Research Summaries
Researchers from Lombardi Comprehensive Cancer Center/Georgetown University Medical Center are presenting numerous scientific findings at the Seventh Annual AACR International Conference on Frontiers in Cancer Prevention Research in Washington, Nov. 16-19, 2008.

Long-Term TITAN Study Evaluates PREZISTA(R)/ritonavir Vs. Lopinavir/ritonavir As Part Of HIV Combination Therapy In Treatment-Experienced Adults
Tibotec recently announced long-term study results from a phase 3 clinical trial, which compared PREZISTA(R) (darunavir)/ritonavir to lopinavir/ritonavir, as part of HIV combination therapy, in lopinavir/r-naive, treatment-experienced HIV-1 infected adults. A 96-week resistance analysis from the study, known as TITAN, was presented in an oral presentation at the Ninth International Congress on Drug Therapy in HIV Infection (HIV9) in Glasgow, UK on November 13, 2008.

Individuals With HIV Have Higher Risk Of Non-AIDS Cancers
The risk of non-AIDS cancer is higher for individuals infected with HIV than for the general population, according to a meta-analysis presented here at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research. Compared with the general population, the risk for non-AIDS cancers was 2.3 times higher for men with HIV and 1.5 times greater for women with HIV.

Teaching Breast Health Early To Reduce Breast Cancer Mortality In D.C.
Early breast health education may be the key to lowering breast cancer mortality rates in Washington, D.C., which has the highest rates in the country, according to research presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research.

ER/PR Negative Tumors Associated With Insurance Status
African-American women are at a higher risk for ER/PR negative breast cancer. A new study, to be presented at the American Association for Cancer Research's Seventh Annual International Conference on Frontiers in Cancer Prevention Research, found that race, socioeconomic characteristics and other tumor characteristics are all important predictors of having ER/PR negative breast cancer.

8,000 Pharmaceutical Scientists To Gather In Atlanta For The American Association Of Pharmaceutical Scientists' Annual Meeting And Exposition
On November 16-20, 2008, 8,000 of the world's most prominent pharmaceutical scientists will put their best research on paper and present their findings at the AAPS Annual Meeting and Exposition. This year's meeting will take place in Atlanta at the Georgia World Congress Center.

World Leaders In Infectious Diseases To Convene And Discuss Developments In Research, Prevention And Treatment
Nearly 2,900 physicians and scientists from institutions around the world such as the World Health Organization, the Centers for Disease Control and the National Institutes of Health will meet at the 57th American Society of Tropical Medicine and Hygiene's Annual Meeting Dec. 7-11, in New Orleans to discuss the latest research on infectious and emerging diseases and global health threats. Meeting highlights include: "Airport Malaria" - Cause for Concern in the U.S.

Conference, Nov. 23-25: Animal And Biological Science Highlights San Antonio Fluid Dynamics
From dolphins to clams to flying creatures like hummingbirds and bats, many of nature's most fascinating creatures exhibit forms of fluid flow. When the 61st Annual Meeting of the American Physical Society (APS) Division of Fluid Dynamics takes place from November 23-25 at the San Antonio Convention Center, researchers from across the globe will describe cutting-edge research with applications in astronomy, engineering, alternative energy, biology, and medicine.